A STUDY OF CLINICAL PHARMACIST INITIATED INTERVENTION FOR THE OPTIMAL USE OF MEDICATIONS IN A NEONATAL INTENSIVE CARE UNIT (NICU) OF A TERTIARY CARE HOSPITAL, SOUTH INDIA
Objective: Various strategies to reduce errors have been described in adult and pediatric patients, but there are few published data on their effect in the NICU. The study was carried out to assess the impact of a clinical pharmacist-initiated intervention for the optimal use of medications in NICU.
Methods: A prospective, non-experimental, Interventional study was conducted, with a sample size of 150 patients, admitted to the NICU during a period of 7 mo.
Results: A total of 87 Drug-related problems (DRPs) were identified from 80 patient case records. Most of the pharmacist-initiated interventions carried out in this study resulted from Dose/frequency inappropriate (40.22%) followed by Administration errors (31.05%) and Drug Interactions (17.24%). The acceptance rate of recommendation and change in drug therapy was found to be high 68.97%. Most of the pharmacist interventions were seen to have moderate significance in grade.
Conclusion: This study demonstrates that the physician's acceptance rate of pharmacist intervention is high. The physician acceptance rate of documented clinical pharmacist interventions indicated that specialist medical colleagues considered most of the interventions appropriate. This suggests that a joint effort between physicians and pharmacist is possible that provides a safer system, improved pharmaceutical care and better resource utilization.
2. Okamoto E, Rassin DK, Zucker CL. Role of taurine in feeding the low-birth-weight infant. J Pediatr 1984;104:936â€“40.
3. Levy M. Vancomycin-induced red man syndrome. J Pediatr 1990;86:572-80.
4. Lerner RB. Medication errors in a neonatal intensive care unit. J Pediatr 2008;84:166-70.
5. Schellack N. Antibiotic prescribing patterns in a neonatal intensive care unit. Southern Afr J Infect Dis 2011;26:267-70.
6. Struck P. A pilot study of pharmacist-initiated interventions in drug therapy in an Australian pediatrics hospital. Eur J Hospital Pharm Sci 2007;13:105-12.
7. Simpson JH. Reducing medication errors in the neonatal intensive care unit. Archives Disease Childhood Fetal Neonatal ED 2004;89:F480â€“2.
8. Jain S. Medication errors in neonates admitted in the intensive care unit and emergency department. Indian J Med Sci 2009;63:145-51.
9. Stavroudis TA. NICU medication errors: identifying a risk profile for medication errors in the neonatal intensive care unit. J Perinatol 2010;30:459â€“68.
10. Kaushal R. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-20.
11. Ganachari MS. Assessment of drug therapy interventions by clinical pharmacist in a tertiary care hospital. Indian J Pharm Practice 2010;3:22-8.
12. Mahmood A. Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit in Karachi. J Pak Med Assoc 2002;52:348-50.
13. Hassan YH. An analysis of clinical pharmacist interventions in an intensive care unit. J Clin Pharm Ther 1992;17:347-51.
14. Raju TN. Medication errors in neonatal and pediatric intensive care units. Lancet 1989;334:374â€“6.